arrow
R

Rosaria Volpini

University of Camerino
H指数:36
被引数:5,091

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design, synthesis, and pharmacological evaluation of thiazolo[5,4-d]pyrimidines hybridized with lipoic acid or catechol. Novel A2A adenosine receptor antagonists in neuroinflammatory diseases

噻唑并[5,4-d]嘧啶与硫辛酸或儿茶酚杂合物的设计、合成与药理学评价:神经炎症疾病中的新型A2A腺苷受体拮抗剂

2026-06-010
OAAI
A Holistic Approach to Identifying a Positron Emission Tomography (PET) Tracer Candidate for In Vivo Imaging of Purinergic P2X7 Receptor in Neuroinflammation

综合方法用于识别用于神经炎症中嘌呤能P2X7受体在体成像的PET示踪剂候选物

2026-03-010
PRE
RETRACTED: Zuccarini et al. Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A1 Receptor Ligands. Cells 2021, 10, 3560

撤回:Zuccarini等人. 正常体重和肥胖受试者皮下脂肪组织中多能基质细胞:腺苷A1受体配体对其脂肪分化的调控。Cells 2021, 10, 3560

2025-09-100
OAAI
8-Amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives hybridized with antioxidants: new highly potent and selective human A2A adenosine receptor antagonists as useful agents against cerebral ischemia

8-氨基-1,2,4-三唑并[4,3-a]吡嗪-3-酮衍生物与抗氧化剂杂化的化合物:作为有效对抗脑缺血的新型高活性、高选择性人A2A腺苷受体拮抗剂

2025-08-060
OA
A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment
2025-04-010
OA
Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta

2-氨基苯并咪唑衍生物作为蛋白激酶CK1 δ 的新抑制剂的结构研究

2024-04-070
OAAI
Dual Anta-Inhibitors of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies

A2A腺苷受体和酪蛋白激酶CK1delta的双重Anta抑制剂: 合成,生物学评估和分子模型研究

2023-01-237
OAAI